VasoRX — Atherosclerosis and Pulmonary Arterial Hypertension Therapy
Verified[Human Health and Wellbeing] Grant investigators: Heather Youngs and Chris Somerville This page was reviewed but not written by the grant investigators. VasoRX staff also reviewed this page prior to publication. Open Philanthropy recommended an investment of $5,550,000 in VasoRX to continue work testing a new therapy for vascular diseases such as atherosclerosis and pulmonary arterial hypertension. This seed-stage investment is intended to support additional research and development in the hopes that VasoRX can subsequently raise additional funds from other investors to conduct a clinical trial of the therapy in humans. This follows our April 2018 support and falls within our work on scientific research, specifically within our interest in advancing human health and wellbeing.
Other Grants by Coefficient Giving
2625| Grant | Recipient | Amount | Date |
|---|---|---|---|
| Janaagraha — Air Quality Grants Assessment | $195K | Dec 2024 | |
| Futurewise — Housing Advocacy in Washington | $450K | Apr 2023 | |
| Exscientia — Agonists for Interferon Lambda | $2.3M | Sep 2023 | |
| Kurzgesagt — Short-form Video Content | $3M | Mar 2022 | |
| Kurzgesagt — Video Production (2023) | $1.7M | May 2023 | |
| Kurzgesagt — Video Creation and Translation | $2.6M | Dec 2021 | |
| Lightcone Infrastructure – General Support | Lighthaven (Event Venue) | $4.5M | Sep 2022 |
| Lightcone Infrastructure — General Support (2023) | Lighthaven (Event Venue) | $3M | Oct 2023 |
| Conjecture — Cybersecurity Bootcamp | Conjecture | $223K | Jun 2025 |
| Conjecture — AI Safety Technical Program | Conjecture | $224K | May 2023 |